Search Results
Immune checkpoint inhibitors in mCRPC
The role of immune checkpoint inhibitors in mCRPC
Cancer Immune Checkpoint Inhibitors
Sumit K. Subudhi, MD, PhD, discusses combining checkpoint inhibitors in mCRPC
Immune checkpoint inhibitors in prostate cancer: Current and future practice
TMB as a predictive biomarker for ICI versus taxane chemotherapy benefit in mCRPC
Tanya Dorff, MD, on how checkpoint inhibitors are being incorporated into mCRPC treatment algorithms
Checkpoint Inhibitor Therapy in Prostate Cancer
AMG 160: immunotherapy for mCRPC
Dr. Graff on the Role of Checkpoint Inhibitors in Prostate Cancer
Advances in the role of ICIs in metastatic CRPC
Side effects of immune checkpoint inhibitors
